Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOPDAPT-3: Prasugrel Monotherapy vs 1-Month DAPT After PCI in HBR or ACS Patients
NCT04609111Phase 4Active, not recruiting
- Sponsor
- Kyoto University
- Start
- Jan 2021
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prasugrel, aspirin in acute coronary syndrome (ACS), sponsored by Kyoto University. Started Jan 2021; status: active, not recruiting.
02
Drugs
prasugrelaspirin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04609111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04609111.